Point-of-care testing: state-of-the art and perspectives
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index, and 1 are not checked yet; 17 of the 49 sources its claims cite were checked for support.
Abstract
Point-of-care testing (POCT) is becoming an increasingly popular way to perform laboratory tests closer to the patient. This option has several recognized advantages, such as accessibility, portability, speed, convenience, ease of use, ever-growing test panels, lower cumulative healthcare costs when used within appropriate clinical pathways, better patient empowerment and engagement, and reduction of certain pre-analytical errors, especially those related to specimen transportation. On the other hand, POCT also poses some limitations and risks, namely the risk of lower accuracy and reliability compared to traditional laboratory tests, quality control and connectivity issues, high dependence on operators (with varying levels of expertise or training), challenges related to patient data management, higher costs per individual test, regulatory and compliance issues such as the need for appropriate validation prior to clinical use (especially for rapid diagnostic tests; RDTs), as well as additional preanalytical sources of error that may remain undetected in this type of testing, which is usually based on whole blood samples (i.e., presence of interfering substances, clotting, hemolysis, etc.). There is no doubt that POCT is a breakthrough innovation in laboratory medicine, but the discussion on its appropriate use requires further debate and initiatives. This collective opinion paper, composed of abstracts of the lectures presented at the two-day expert meeting "Point-Of-Care-Testing: State of the Art and Perspective" (Venice, April 4-5, 2024), aims to provide a thoughtful overview of the state-of-the-art in POCT, its current applications, advantages and potential limitations, as well as some interesting reflections on the future perspectives of this particular field of laboratory medicine.
Verified 2026-11-22 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
This collective opinion paper summarizes lectures from a 2024 Venice expert meeting on point-of-care testing (POCT), covering its advantages, limitations, applications, quality requirements, and future perspectives. It concludes that POCT is a breakthrough innovation but requires appropriate governance, quality systems, training, standardization, and better outcome/health-technology-assessment evidence.
Key findings
- POCT offers accessibility, portability, speed, convenience, lower cumulative healthcare costs when used in appropriate clinical pathways, patient empowerment, and reduced specimen-transport preanalytical errors, but risks lower accuracy/reliability, quality-control and connectivity issues, operator dependence, data-management challenges, higher per-test costs, regulatory/compliance issues, and additional preanalytical errors such as interfering substances, clotting, and hemolysis.
- Quality and accreditation: ISO 15189:2022 now includes POCT requirements from ISO 22870; for glucose POCT, positive patient identification (PPID) was a high-risk preanalytical indicator, with higher compliance where glucose meters were connected to the electronic health record; quality-control failures were mostly vial switches (33–72%); discordant critically high glucose results were linked to insufficient hand washing and line contamination.
- Application-specific evidence: continuous glucose monitoring (CGM) is recommended for insulin-treated diabetes and has been associated with lower HbA1c and fewer hypoglycemic events; manual transcription of glycemia results was incorrect for time or concentration in approximately 3% of cases, with about 7% of those potentially leading to insulin dosing errors; hemoglobin excess differences >1 g/dL occurred in 1.43%; COVID-19 rapid antigen test sensitivity was 34.4%, improving to 55.3% on repeat and 68.5% on a third test, with specificity assumed 99.2% and prevalence boundaries of 7.37%, 10.46%, and 14.22% at a false omission rate of 5%; NRL evaluations found significant performance differences and 6 of 92 SARS-CoV-2 antigen RDTs non-compliant.
- Value and networks: a review of 84 studies found 50% were correlation studies and only 13% evaluated impact on clinical practice; few health technology assessment reports exist and are often negative because they focus on analytical/preanalytical aspects; the Wales POCT network connected over 3,200 devices across 35 interfaces for a population of nearly 3.1 million.
Methods
- Design: collective opinion paper composed of abstracts of lectures presented at the two-day expert meeting “Point-Of-Care-Testing: State of the Art and Perspective” (Venice, April 4–5, 2024), including a table summarizing the lectures.
- Data or sample: no primary patient sample or systematic review; narrative overview of POCT state-of-the-art, current applications, advantages, limitations, and future perspectives across clinical settings and technologies.
- Main analysis: narrative/opinion synthesis without a stated quantitative meta-analysis; research ethics and informed consent were not applicable, no funding was declared, and the authors state no conflicts of interest.
Limitations
- Stated: there is a lack of complete, comprehensive, global evaluation of POCT impact; most studies report analytical performance rather than patient outcomes; clinical outcomes “have never been adequately evaluated”; randomized clinical trials and health technology assessment reports are compellingly needed; CGM lacks international acceptance criteria and study procedures, making performance comparisons difficult; POCT quality-assurance barriers include different sample types, cost/shipping/importation, lack of infrastructure, fixed test dates, and loss of QA data.
- Stated: during COVID-19, Emergency Use Listing reduced performance-evidence requirements, more than 700 SARS-CoV-2 IVDs were available by June 2020, post-market assessment was generally not required, and “we are not ready to face a new pandemic.”
- Evident: as an opinion paper based on meeting abstracts, it does not provide a systematic search, risk-of-bias assessment, or primary data; conclusions reflect expert perspectives and selected cited studies rather than a formal evidence synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 19 Not valid · 32 Not checked · 44 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, we are not ready to face a new pandemic [38].”
What the sources say
- Partly supportedcites [38] 38. Escadafal C, Baldan R, De Vos M, Ruiz RJ, Emperador DM, Murahwa AT, et al. Evaluating diagnostic tests during outbreaks: challenges and lessons learnt from COVID-19. BMJ Glob Health 2023;8:e01250. sourceExperimental — accuracy not yet measured
The Conclusions say that the funding gap for diagnostic preparedness continues to widen and must be addressed before the next public health threat. This supports concern about readiness in diagnostics, but not the broader claim that we are unprepared for a new pandemic overall. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: unclear — It is unclear whether it could be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fi rst systematic geospatial analysis for optimal positioning of POCT resources was conducted in a remote island setting, the Bantayan Archipelago, Visayas Islands, Philippines [50].”
What the sources say
- Partly supportedcites [50] 50. Kost GJ, Fuzery AK, Caratao LKR, Tinsay S, Zadran A, Ybanez AP. Using geographic rescue time intervals, point-of-care strategies, and spatial care paths to prepare island communities for global warming, rising oceans, and weather disasters. Intl J Health Geogr 2023;38:1 -22. sourceExperimental — accuracy not yet measured
The Methods (Geospatial analysis; page not provided) describe rescue-time contour mapping in the Bantayan Archipelago to determine where to position POCT, and the Conclusions propose sites. Our copy does not establish that this was the first systematic geospatial analysis of its kind. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The implementation of POCT outside the laboratory has facilitated access to diagnostics for remote and regional populations, disadvantaged communities and individuals at high risk of infection [66].”
What the sources say
- Partly supportedcites [66] 66. Land KJ, Boeras DI, Chen XS, Ramsay AR, Peeling RW. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol 2019;4:46 -54. sourceExperimental — accuracy not yet measured
The ASSURED criteria section (page unavailable) explains that point-of-care tests can serve community and primary-care settings with limited laboratory access, and the implementation section describes rapid testing in the Amazon forest and rural China. The paper also discusses increased access in low- and middle-income countries, but the passages found do not establish improved access specifically for individuals at high risk of infection. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“An independent FDA-university-commercial evaluation of RAgTs provided repeat home testing performance data [66] used in theoretical calculations.”
What the sources say
- Could not verifycites [66] 66. Land KJ, Boeras DI, Chen XS, Ramsay AR, Peeling RW. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol 2019;4:46 -54. sourceExperimental — accuracy not yet measured
The ASSURED diagnostic tests section discusses rapid tests for HIV, malaria, syphilis and TB, not an independent evaluation of repeat at-home RAgT testing. Searches for FDA–university–commercial evaluation and serial home-testing performance found no passage addressing the attributed data; the copy provides no page numbers for these passages. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Thus, considering that POCT is commonly performed in healthcare settings located outside of direct jurisdiction and control of the laboratory, reinforced education on all potential preanalytical errors must be delivered to all healthcare professionals who have direct responsibility for performing POCT [64].”
What the sources say
- Partly supportedcites [64] 64. Baird G. Preanalytical considerations in blood gas analysis. Biochem Med 2013;23:19 -27. sourceExperimental — accuracy not yet measured
The POC Considerations section says point-of-care blood gas testing is common in operating rooms, emergency rooms, and the field, supporting the claim that it often occurs outside the laboratory. It does not establish that those settings are outside the laboratory’s direct jurisdiction or control; physical location alone does not settle that qualifier. The sentence’s call for reinforced education is the citing authors’ conclusion, not the point assessed here. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
32 more claims
Create a free account to see all 106 claims and to verify the 18 references still open.
- It may state two separate claims as one. 50
- The quote only partly states this claim. 1
- Probably not a substantial claim. 32
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, clinical guidelines generally recommend confirmatory laboratory testing when POCT values fall near critical therapeutic thresholds [11].”
From Reliability of Point-of-Care Venous Blood Gas Testing for Potassium and Sodium Compared to Central Laboratory Results in Emergency Patients: A Clinical Audit (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Plebani et al. [11] emphasized that, when implemented under controlled conditions with appropriate quality assurance, decentralized POCT systems can alleviate ED crowding and improve triage flow.”
From Reliability of Point-of-Care Venous Blood Gas Testing for Potassium and Sodium Compared to Central Laboratory Results in Emergency Patients: A Clinical Audit (2025) · cites this paper as Plebani et al. [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ POCT and evidence-based laboratory medicine (EBLM) does it leverage any advantage in clinical decision making?
“a study evaluating the antibiotic prescription in six UK sites”
§ POCT and evidence-based laboratory medicine (EBLM) does it leverage any advantage in clinical decision making?
“a decrease of 20 % in prescription in fi ve sites, a decrease of 60 % in one site and no e ff ects in the remaining.”
Citations
Cites
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
International Organization for Standardization (ISO)
Nahler, G. (2009) · Dictionary of Pharmaceutical Medicine · doi:10.1007/978-3-211-89836-9_723 · Cited by 3,677
Land, K. J., Boeras, D. I., Chen, X.-S., Ramsay, A. R., & Peeling, R. W. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0295-3 · Cited by 1,065
The emergence of AI-based wearable sensors for digital health technology: a review
Shajari, S., Kuruvinashetti, K., Komeili, A., & Sundararaj, U. (2023) · Sensors · doi:10.3390/s23239498 · Cited by 535
Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30297-6 · Cited by 522
Self-citation(2015) · doi:10.1002/ejhf.289 · Cited by 417
Preanalytical quality improvement: from dream to reality
Lippi, G., Chance, J. J., Church, S., Dazzi, P., Fontana, R., Giavarina, D., Grankvist, K., Huisman, W., Kouri, T., Palicka, V., et al. (2011) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2011.600 · Cited by 388
Self-citationThe Brain-to-Brain Loop Concept for Laboratory Testing 40 Years After Its Introduction
Plebani, M., Laposata, M., & Lundberg, G. D. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpr28hwhssdnon · Cited by 212
Self-citationMobile real-time surveillance of Zika virus in Brazil
Faria, N. R., Sabino, E. C., Nunes, M. R. T., Alcantara, L. C. J., Loman, N. J., & Pybus, O. G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0356-2 · Cited by 195
Diagnostic Errors in the Emergency Department: A Systematic Review
Newman-Toker, D. E., Peterson, S. M., Badihian, S., Hassoon, A., Nassery, N., Parizadeh, D., Wilson, L. M., Jia, Y., Omron, R., Tharmarajah, S., et al. (2022) · doi:10.23970/ahrqepccer258 · Cited by 188
Nichols, J. H., Christenson, R. H., Clarke, W., Gronowski, A., Hammett-Stabler, C. A., Jacobs, E., Kazmierczak, S., Lewandrowski, K., Price, C., Sacks, D. B., et al. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.12.025 · Cited by 169
Self-citationLippi, G., von Meyer, A., Cadamuro, J., & Simundic, A.-M. (2019) · Diagnosis · doi:10.1515/dx-2018-0018 · Cited by 135
Self-citationDoes POCT reduce the risk of error in laboratory testing?
Plebani, M. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.014 · Cited by 97
Self-citationPreanalytical considerations in blood gas analysis
Baird, G. (2013) · Biochemia Medica · doi:10.11613/bm.2013.005 · Cited by 90
Freckmann, G., Eichenlaub, M., Waldenmaier, D., Pleus, S., Wehrstedt, S., Haug, C., Witthauer, L., Jendle, J., Hinzmann, R., Thomas, A., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231190941 · Cited by 86
Self-citationYan, L., Xiao, H., & Zhang, Q. (2016) · Tuberculosis · doi:10.1016/j.tube.2015.11.005 · Cited by 72
Hicks, J. M., Haeckel, R., Price, C. P., Lewandrowski, K. B., & Wu, A. H. B. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00400-9 · Cited by 72
Soni, A., Herbert, C., Lin, H., Yi, Y., Pretz, C., Stamegna, P., Wang, B., Orwig, T. A., Wright, C., Tarrant, S., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0385 · Cited by 67
Standardization process of continuous glucose monitoring: Traceability and performance
Freckmann, G., Nichols, J. H., Hinzmann, R., Klonoff, D. C., Ju, Y., Diem, P., Makris, K., & Slingerland, R. J. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.12.025 · Cited by 62
Self-citationThe application of nanoparticles in point-of-care testing (POCT) immunoassays
Hou, F., Sun, S., Abdullah, S. W., Tang, Y., Li, X., & Guo, H. (2023) · Analytical Methods · doi:10.1039/d3ay00182b · Cited by 61
Meissen, H. H., Gong, M. N., Wong, A.-K. I., Zimmerman, J. J., Nadkarni, N. M., Kane‐Gill, S. L., Amador-Castaneda, J., Bailey, H., Brown, S. M., DePriest, A., et al. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000659 · Cited by 59
Point-of-care testing: where is the evidence? A systematic survey
Pecoraro, V., Germagnoli, L., & Banfi, G. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0386 · Cited by 56
Self-citationEichenlaub, M., Pleus, S., Rothenbühler, M., Bailey, T. S., Bally, L., Brazg, R., Bruttomesso, D., Diem, P., Boija, E. E., Fokkert, M. J., et al. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0465 · Cited by 55
Self-citationFerguson, W., Kemp, K. K., & Kost, G. J. (2016) · International Journal of Health Geographics · doi:10.1186/s12942-016-0037-9 · Cited by 46
Self-citationISO 15189 Accreditation: Navigation Between Quality Management and Patient Safety
Plebani, M., & Sciacovelli, L. (2017) · Journal of Medical Biochemistry · doi:10.1515/jomb-2017-0038 · Cited by 44
Self-citationFlowing through laboratory clinical data: the role of artificial intelligence and big data
Padoan, A., & Plebani, M. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0653 · Cited by 42
Self-citationAccreditation process in European countries – an EFLM survey
Boursier, G., Vukasovic, I., Brguljan, P. M., Lohmander, M., Ghita, I., Bernabeu Andreu, F. A., Barrett, E., Brugnoni, D., Kroupis, C., Sprongl, L., et al. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0780 · Cited by 42
Kost, G. J. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00329 · Cited by 38
Self-citationPost-analytical errors with portable glucose meters in the hospital setting
Carraro, P., & Plebani, M. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.013 · Cited by 37
Self-citationRapid roll out of SARS-CoV-2 antibody testing—a concern
Andersson, M., Low, N., French, N., Greenhalgh, T., Jeffery, K., Brent, A., Ball, J., Pollock, A., McCoy, D., Iturriza-Gomara, M., et al. (2020) · BMJ · doi:10.1136/bmj.m2420 · Cited by 31
Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian?
Dhesi, Z., Enne, V. I., O‘Grady, J., Gant, V., & Livermore, D. M. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00027 · Cited by 30
Newdemics, public health, small-world networks, and point-of-care testing
Kost, G. J. (2006) · Cited by 28
Self-citationHuggett, J. F., O’Sullivan, D. M., Cowen, S., Cleveland, M. H., Davies, K., Harris, K., Moran‐Gilad, J., Winter, A., Braybrook, J. H., & Messenger, M. P. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101275 · Cited by 27
Self-citationImproving the Bias of Comparator Methods in Analytical Performance Assessments Through Recalibration
Pleus, S., Eichenlaub, M., Gerber, T., Eriksson Boija, E., Makris, K., Haug, C., & Freckmann, G. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221133107 · Cited by 24
Self-citationLaboratory medicine and natural disasters: are we ready for the challenge?
(2010) · doi:10.1515/cclm.2010.148 · Cited by 23
Self-citationKost, G. J. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0716-sa · Cited by 23
Self-citationDiagnostic Strategies for Endemic Coronavirus Disease 2019 (COVID-19)
Kost, G. J. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0386-sa · Cited by 22
Self-citationFüzéry, A. K., & Kost, G. J. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0268-oa · Cited by 18
Self-citationBlood over-testing: impact, ethical issues and mitigating actions
Pennestrì, F., Tomaiuolo, R., Banfi, G., & Dolci, A. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-1227 · Cited by 18
Self-citationA systematic evaluation of immunoassay point-of-care testing to define impact on patients’ outcomes
Pecoraro, V., Banfi, G., Germagnoli, L., & Trenti, T. (2017) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563217694377 · Cited by 17
Self-citationDimech, W. J., Walker, S., Jardine, D. K., Read, S., Smeh, K., Karakaltsas, M., Dent, B., & Dax, E. M. (2004) · Accreditation and Quality Assurance · doi:10.1007/s00769-003-0734-5 · Cited by 17
Self-citation(2022) · doi:10.1007/s00216-022-03987-8 · Cited by 16
Self-citationQi, M., Naranjo, A. R., Duque, A. J., Lorey, T. S., Schapiro, J. M., Suh-Burgmann, B. J., Rummel, M., Salipante, S. J., Wentzensen, N., & Greene, D. N. (2024) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2024.02.006 · Cited by 15
Self-citationShaw, J. L., McCudden, C. R., Colantonio, D. A., Booth, R. A., Lin, D. C., Blasutig, I. M., Moran, T., Trofimczuk, D., Carriere, C., Gharra, A., et al. (2020) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2020.e00184 · Cited by 14
Self-citationFüzéry, A. K., Elian, F., & Kost, G. J. (2022) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2022.08.013 · Cited by 13
Self-citationThe Coronavirus Disease 2019 Spatial Care Path: Home, Community, and Emergency Diagnostic Portals
Kost, G. J. (2022) · Diagnostics · doi:10.3390/diagnostics12051216 · Cited by 13
Self-citationBayés‐Genís, A., & Rosano, G. M. C. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2950 · Cited by 13
Evaluating diagnostic tests during outbreaks: challenges and lessons learnt from COVID-19
Escadafal, C., Baldan, R., De Vos, M., Ruiz, R. J., Emperador, D. M., Murahwa, A. T., Macé, A., Bausch, D. G., Vessière, A., & Sacks, J. A. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012506 · Cited by 9
Kost, G. J. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0443-sa · Cited by 9
Self-citationDevelopment and validation of an LC-MSMS method to quantify creatinine from dried blood spots
(2024) · doi:10.1016/j.jmsacl.2024.03.001 · Cited by 9
Self-citationShaw, J. L. V., Arnoldo, S., Beach, L., Bouhtiauy, I., Brinc, D., Brun, M., Collier, C., Kostantin, E., Fung, A. W. S., Füzéry, A. K., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0147 · Cited by 9
Self-citation(2023) · doi:10.1016/j.jmsacl.2023.10.002 · Cited by 9
Self-citationKost, G. J., Füzéry, A. K., Caratao, L. K. R., Tinsay, S., Zadran, A., & Ybañez, A. P. (2023) · International Journal of Health Geographics · doi:10.1186/s12942-023-00359-y · Cited by 8
Self-citationStoffel, M., Beal, S. G., Ibrahim, K. A., Rummel, M., & Greene, D. N. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2258973 · Cited by 7
Self-citationKost, G. J. (2023) · Diagnostics · doi:10.3390/diagnostics13203223 · Cited by 5
Self-citationPoint-of-Care Testing and Public Health
Kost, G. J. (2006) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/01.poc.0000243982.38385.d2 · Cited by 5
Self-citationNaranjo, A. R., Krasowski, M. D., Hamdan, A., O’Connor, K., Carter, C. L., Chen, J., & Greene, D. N. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119676 · Cited by 4
Self-citationTransdermal measurement of cardiac troponins: the future is now
(2022) · doi:10.1515/cclm-2022-0382 · Cited by 4
Self-citation(2023) · doi:10.20944/preprints202308.1497.v1 · Cited by 4
Self-citationComprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays
Dimech, W., Curley, S., Subissi, L., Ströher, U., Perkins, M. D., & Cunningham, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05101-22 · Cited by 4
Self-citationComprehensive, comparative evaluation of 25 automated SARS-CoV-2 serology assays
Dimech, W., Curley, S., & Cai, J. J. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03228-23 · Cited by 4
Self-citationEffect of syringe underfilling on the quality of venous blood gas analysis
Lippi, G., Pighi, L., Tosi, M., Vettori, M., Celegon, G., Favaloro, E. J., & Salvagno, G. L. (2023) · Diagnosis · doi:10.1515/dx-2023-0096 · Cited by 3
Self-citationDimech, W., Lamoury, F., Ding, X. C., Lastra, L. M., Vincini, G., & Sands, A. (2022) · IJQHC Communications · doi:10.1093/ijcoms/lyac010 · Cited by 3
Self-citationDecreasing the Lower Limit of Quantitation for Urine Albumin Improves Clinical Utility
Greene, D. N., Marzinke, M. A., Carter, C. L., Chen, J., Hoenig, M. P., & Rummel, M. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfac046 · Cited by 2
Self-citationFalse-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers
Hage-Sleiman, M., Tremeaux, P., Fillion, M., Boufassa, F., Melard, A., Gardiennet, E., Mariaggi, A.-A., Plantier, J.-C., Rouzioux, C., Lambotte, O., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz734 · Cited by 2
A-361 Implementation of a Fit-for-purpose Point of Care Quality Assurance Program
Dimech, W. J., Cabuang, L., & Vincini, G. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad097.319 · Cited by 1
Self-citationKhan, A. I., & Wu, A. H. B. (2021) · Self-Assessment Q&A in Clinical Laboratory Science, III · doi:10.1016/b978-0-12-822093-1.00037-5
Self-citation(2021) · PubMed Central
Self-citationB-203 Development and Validation of an LC/MS/MS Method to Quantify Creatinine in Dried Blood Spots
Torres, C., Muldrow, R., & Greene, D. N. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad097.532
Self-citationThe ‘10 commandments’ for the 2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R., Coughlan, J. J., Rossello, X., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehad863
Kost, G. J., Füzéry, A. K., Caratao, L. K. R., Tinsay, S., Zadran, A., & Ybañez, A. P. (2023) · doi:10.21203/rs.3.rs-3182988/v1
Self-citationPerformance of Rapid Antigen Tests to Detect Symptomatic and Asymptomatic SARS-CoV-2 Infection
Soni, A., Herbert, C., Lin, H., Yan, Y., Pretz, C., Stamegna, P., Wang, B., Orwig, T., Wright, C., Tarrant, S., et al. (2022) · doi:10.1101/2022.08.05.22278466
Nichols, J. H. (2007) · Point of Care: The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0b013e3180a0253d
Self-citation
Research works printed but not linked: 6
- 1. Kost GJ. Guidelines for point-of-care testing. Improving patient outcomes. Am J Clin Pathol 1995;104:S111 -27.
- 13. Hockman B, Qi M, Rotblatt H. Overcoming analytical and preanalytical challenges associated with extra-genital home collected STI specimens. J Clin Microbiol. in press.
- 32. International Medical Device Regulators Forum. Essential principles of safety and performance of medical devices and IVD medical devices, IMDRF good regulatory review practices group, Editor 2018. Available from: https://www.imdrf.org/documents/essential-principles-safetyand-performance-medical-devices-and-ivd-medical-devices [Accessed 24 May 2024].
- 52. Fuzery AK, Kost GJ. Point-of-care testing by ambulance teams: an opportunity for a new standard. Clin Lab News 2021;47:8 -13.
- 58. National Institute for Health and Care Excellence. Suspected acute respiratory infection in over 16s: assessment at fi rst presentation and initial management. London: National Institute for Health and Care Excellence (NICE); 2023. (NICE Clinical Guidelines, No. 237) Available from https://www.ncbi.nlm.nih.gov/books/NBK598565/ [Accessed 8 May 2024].
- 72. Kost GJ. Changing diagnostic culture calls for point-of-care preparedness -multiplex now, open prevalence boundaries, and build community resilience. J 21st Century Pathol 2022;2:129.
Cited by
AI-Reinforced Wearable Sensors and Intelligent Point-of-Care Tests
Yammouri, G., & Lahcen, A. A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14111088 · Cited by 104
Maximising the translation potential of electrochemical biosensors
Docherty, N., Macdonald, D., Gordon, A., Dobrea, A., Mani, V., Fu, Y., Pang, S., Jimenez, M., & Corrigan, D. K. (2025) · Chemical Communications · doi:10.1039/d5cc02322j · Cited by 64
Point-of-Care Testing: The Convergence of Innovation and Accessibility in Diagnostics
Augustine, S., Venkadesh, A., Kaushal, S., Lee, E., Ajaj, M., & Lee, N. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c07075 · Cited by 58
Kardjadj, M. (2025) · Diagnostics · doi:10.3390/diagnostics15222845 · Cited by 76
Advancing clinical biochemistry: addressing gaps and driving future innovations
Cao, H., Oghenemaro, E. F., latypova, A., Abosaoda, M. K., Zaman, G. S., & Devi, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1521126 · Cited by 61
Metadata
- Authors
- Plebani, M., Nichols, J. H., Luppa, P. B., Greene, D., Sciacovelli, L., Shaw, J., Khan, A. I., Carraro, P., Freckmann, G., Dimech, W., Zaninotto, M., Spannagl, M., Huggett, J., Kost, G. J., Trenti, T., Padoan, A., Thomas, A., Banfi, G., & Lippi, G.
- Affiliations
- University of Padua (IT)
- Vanderbilt University Medical Center (US)
- TUM Klinikum (DE)
- University of Washington (US)
- University of Ottawa (CA)
- Temple University (US)
- Department of Laboratory Medicine , Venice Hospital , Venice , Italy
- Universität Ulm (DE)
- National Serology Reference Laboratory , Melbourne , Australia
- Institut für Laboratoriumsmedizin (DE)
- LGC (GB)
- University of California System (US)
- Laboratory Medicine and Pathology Department AUSL e AOU Modena , Modena , Italy
- National Health Service Wales (GB)
- Vita-Salute San Raffaele University (IT)
- University of Verona (IT)
- Corresponding author
- Plebani, Mario
- ORCID
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2024-06-17
- Volume
- 63
- Issue
- 1
- Pages
- 35-51
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W4399756441
- Cited by
- 119
- References
- 70
- Citations by year
- 2026: 69 · 2025: 46 · 2024: 4
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- point-of-care testing, rapid diagnostic tests, pre-analytical errors, quality control, test validation, regulatory compliance, patient data management, whole blood samples, health care costs
- MeSH terms
- Point-of-Care Testing, Humans, Point-of-Care Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.